The MQ series MLCCs promise the reliability performance needed by electronic life support applications such as: pacemakers, implantable cardioverter-defibrillators and neuromodulation devices.
AVX has introduced the MQ series medical grade MLCCs that are produced, tested and qualified using rigorous medical design, in-process, and lot acceptance requirements. According to the company, the MLCCs provide the reliability performance needed by electronic life support applications such as: pacemakers, implantable cardioverter-defibrillators (ICDs) and neuromodulation devices.
The MQ series medical-grade MLCCs are available in eight EIA case sizes spanning 0402 to 2225, and four dielectric materials: NP0 (C0G), X7R, X7S, and X5R. Voltage ratings for the series range from 4V to 100V, capacitance values span 1pF to 100μF, and capacitance tolerances extend from ±0.1pF to ±30%. The MQ series capacitors are also available with four termination options: plated Ni/Sn, 60/40 Sn/Pb, 5% minimum Pb-plated solder and gold plated.
The NP0 (C0G), X7R, and X7S MQ series MLCCs are rated for operating temperatures spanning -55°C to 125°C. Operating temperatures for X5R MQ series MLCCs range from -55°C to 85°C. The MQ series capacitors in 0402, 1210, 1812, 1825 and 2225 cases are compatible with reflow soldering, and 0603, 0805 and 1206 cases are compatible with both reflow and wave. Components can be purchased directly from AVX, and are shipped on 7in or 13in reels or in waffle packaging. Lead-time for the series is 15 weeks.
Available in several different dielectrics, case sizes, voltage and capacitance ratings, and termination options, the TS 16949-certified series also offers exceptional versatility, added the company.